X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $79.66 million. The enterprise value is $22.89 million.
Important Dates
The next estimated earnings date is Thursday, March 20, 2025, before market open.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 170.55 million shares outstanding. The number of shares has increased by 30.46% in one year.
| Current Share Class | 170.55M |
| Shares Outstanding | 170.55M |
| Shares Change (YoY) | +30.46% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 6.10% |
| Owned by Institutions (%) | 41.43% |
| Float | 128.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.23 |
| Forward PS | 8.97 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.89, with a Debt / Equity ratio of 1.31.
| Current Ratio | 4.89 |
| Quick Ratio | 4.65 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.67 |
Financial Efficiency
Return on equity (ROE) is -26.35% and return on invested capital (ROIC) is -62.04%.
| Return on Equity (ROE) | -26.35% |
| Return on Assets (ROA) | -46.55% |
| Return on Invested Capital (ROIC) | -62.04% |
| Return on Capital Employed (ROCE) | -87.90% |
| Revenue Per Employee | $12,075 |
| Profits Per Employee | -$180,204 |
| Employee Count | 93 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $85,000 in taxes.
| Income Tax | 85,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.62% in the last 52 weeks. The beta is 0.12, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -47.62% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 41.80 |
| Average Volume (20 Days) | 6,837,944 |
Short Selling Information
The latest short interest is 16.61 million, so 9.74% of the outstanding shares have been sold short.
| Short Interest | 16.61M |
| Short Previous Month | 13.55M |
| Short % of Shares Out | 9.74% |
| Short % of Float | 12.95% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, XFOR had revenue of $1.12 million and -$16.76 million in losses. Loss per share was -$0.09.
| Revenue | 1.12M |
| Gross Profit | 628,000 |
| Operating Income | -130.89M |
| Pretax Income | 17.73M |
| Net Income | -16.76M |
| EBITDA | -130.30M |
| EBIT | -130.89M |
| Loss Per Share | -$0.09 |
Full Income StatementBalance Sheet
The company has $134.98 million in cash and $78.20 million in debt, giving a net cash position of $56.77 million or $0.33 per share.
| Cash & Cash Equivalents | 134.98M |
| Total Debt | 78.20M |
| Net Cash | 56.77M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 59.62M |
| Book Value Per Share | 0.35 |
| Working Capital | 113.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$125.65 million and capital expenditures -$320,000, giving a free cash flow of -$125.97 million.
| Operating Cash Flow | -125.65M |
| Capital Expenditures | -320,000 |
| Free Cash Flow | -125.97M |
| FCF Per Share | -$0.74 |
Full Cash Flow StatementMargins
| Gross Margin | 55.92% |
| Operating Margin | -11,654.94% |
| Pretax Margin | -1,484.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.46% |
| Shareholder Yield | -30.46% |
| Earnings Yield | -21.04% |
| FCF Yield | -158.13% |
Analyst Forecast
The average price target for XFOR is $3.50, which is 649.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.50 |
| Price Target Difference | 649.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XFOR has an Altman Z-Score of -4.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.64 |
| Piotroski F-Score | n/a |